|
⚲
|
| Keyboard |
| Michor Franziska
✚
|
|
|---|---|
| CIK # | 0002045159 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002045159] | |
| 4 | [0002045159] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Michor Franziska | |
| Recursion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-06-18 | Grant | 22,016 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 44,031 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-11-20 | Grant | 17,694 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-11-20 | Grant | 41,390 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-11-20 | Grant | 17,694 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-11-20 | Grant | 30,618 | ||
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-11-20 | Grant | 30,670 | ||
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-11-20 | Grant | 15,286 | ||
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-11-20 | Grant | 82,781 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-11-20 | Grant | 15,335 | $0.00 |